Loading
Kato (Hong Kong) Holdings Ltd. Stock: price and insider trades · Hong Kong
1 insider bought €20k of shares over the last 90 days, the latest by Ngai Shi Shing Godfrey, filed 02 Oct 2026.
Kato (Hong Kong) Holdings Ltd.: what insiders have been doing
Kato (Hong Kong) Holdings Ltd. belongs to the Health Care sector. Filings by its managers are published through HKEX. From 22 October 2025 to 22 October 2026, the disclosure feed for Kato (Hong Kong) Holdings Ltd. logged 28 filings by 2 insiders.
The flow runs one way only: 1 insider bought (27 purchases totalling €691k) and nobody sold on the market. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 1 senior executive. One trade stands out by size: a purchase of €248k from Ngai Shi Shing Godfrey, disclosed on 13 January 2026.
Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 28 filings, this issuer sits above that mark. The full history, which starts in 2019, counts 55 purchases against 1 sale.
The most recent open-market purchase was published on 2 October 2026, 22 days ago. Typically, a trade is published a median of 1 day after it takes place. Until a filing is published, the market cannot know about the trade.
This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Insider Decl.
65
Thresholds
n/a
Buy Volume
€1M
55 ops. · all time
Sell Volume
n/a
1 ops. · all time
Who traded when
BuySaleNgai Shi Shing Godfrey30 buys
Ngai Ka Yee1 buy
Since the insiders bought
- +0.0%Entry HK$0.49 · Close 21 Oct 2026 HK$0.49
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,864 of 26,280 companies
65.7
score / 100
Value71
Quality60
FCF yld15%
Earn yld4.5%
EV/EBITDA8.5x
ROE7.5%
Gross mgn94%
Net mgn6.9%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended March 2025 · cache
HK$0.49
Analyst consensus
Income statement
RevenueHK$317.1M
Gross profitHK$296.8M94% margin
EBITDAHK$96.8M31% margin
Net incomeHK$21.9M9.7% margin
Valuation
PER (trailing)16.3x
P/Book1.1x
Beta0.02
Balance sheet & cash
Market capHK$490M
Total debtHK$333M
Free Cash FlowHK$71.1M
Debt / Equity59%
Profitability & ownership
ROE7.5%
ROA5.0%
% insiders71.2%
% institutions0.0%
Last declaration on 12 October 2026
Declarations65 total
636,096,000 sharesShareXHKGHKEX:DA20261009E00522
84,000 shares@ HK$0.4650.0083% mcap1.7% of flowShareXHKGHKEX:DA20260930E00396
Canonical exit: 29 Dec 2026 (T+90)
32,000 shares@ HK$0.4810.0032% mcap0.7% of flowShareXHKGHKEX:DA20260814E00310
Canonical exit: 12 Nov 2026 (T+90)
200,000 shares@ HK$0.4880.020% mcap4.2% of flowShareXHKGHKEX:DA20260806E00481
Canonical exit: 4 Nov 2026 (T+90)
64,000 shares@ HK$0.480.0065% mcap1.3% of flowShareXHKGHKEX:DA20260724E00430
Canonical exit: 21 Oct 2026 (T+90)
104,000 shares@ HK$0.480.011% mcap2.2% of flowShareXHKGHKEX:DA20260722E00561
Canonical exit: 18 Oct 2026 (T+90)
356,000 shares@ HK$0.4850.037% mcap7.5% of flowShareXHKGHKEX:DA20260717E00029
Canonical exit: 13 Oct 2026 (T+90)
352,000 shares@ HK$0.470.035% mcap7.2% of flowShareXHKGHKEX:DA20260715E00340
Canonical exit: 12 Oct 2026 (T+90)
668,000 shares@ HK$0.4850.066% mcap13.8% of flowShareXHKGHKEX:DA20260409E00397
Canonical exit: 7 Jul 2026 (T+90)
952,000 shares@ HK$0.470.093% mcap19.2% of flowShareXHKGHKEX:DA20260408E00056
Canonical exit: 1 Jul 2026 (T+90)
1,908,000 shares@ HK$0.4650.18% mcap38.0% of flowShareXHKGHKEX:DA20260401E00231
Canonical exit: 29 Jun 2026 (T+90)
148,000 shares@ HK$0.450.014% mcap2.9% of flowShareXHKGHKEX:DA20260330E00189
Canonical exit: 25 Jun 2026 (T+90)
156,000 shares@ HK$0.4450.014% mcap3.0% of flowShareXHKGHKEX:DA20260320E00376
Canonical exit: 17 Jun 2026 (T+90)
72,000 shares@ HK$0.441.3% of flowShareXHKGHKEX:DA20260313E00064
Canonical exit: 10 Jun 2026 (T+90)
200,000 shares@ HK$0.460.7% of flowShareXHKGHKEX:DA20260225E00298
Canonical exit: 25 May 2026 (T+90)
108,000 shares@ HK$0.4350.4% of flowShareXHKGHKEX:DA20260211E00038
Canonical exit: 11 May 2026 (T+90)
296,000 shares@ HK$0.4351.0% of flowShareXHKGHKEX:DA20260204E00074
Canonical exit: 4 May 2026 (T+90)
500,000 shares@ HK$0.441.7% of flowShareXHKGHKEX:DA20260204E00072
Canonical exit: 3 May 2026 (T+90)
108,000 shares@ HK$0.4450.4% of flowShareXHKGHKEX:DA20260202E00020
Canonical exit: 29 Apr 2026 (T+90)
128,000 shares@ HK$0.4450.4% of flowShareXHKGHKEX:DA20260128E00364
Canonical exit: 27 Apr 2026 (T+90)
376,000 shares@ HK$0.451.3% of flowShareXHKGHKEX:DA20260127E00041
Canonical exit: 26 Apr 2026 (T+90)
408,000 shares@ HK$0.441.4% of flowShareXHKGHKEX:DA20260115E00389
Canonical exit: 14 Apr 2026 (T+90)
5,000,000 shares@ HK$0.4517.3% of flowShareXHKGHKEX:DA20260113E00381
Canonical exit: 12 Apr 2026 (T+90)
852,000 shares@ HK$0.452.9% of flowShareXHKGHKEX:DA20260106E00465
Canonical exit: 5 Apr 2026 (T+90)
80,000 shares@ HK$0.450.3% of flowShareXHKGHKEX:DA20260102E00228
Canonical exit: 31 Mar 2026 (T+90)
25 of 65 declarations
About Kato (Hong Kong) Holdings Ltd.
Kato (Hong Kong) Holdings Ltd. is a company operating in the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.
